logo

For the Inventor, By the Inventor

Moorpark, CA, United States of America

Xianghong Wang

This inventor holds 25 USPTO granted patents and 5 published patent applications and 10 EPO patents, primarily in Therapeutic Compounds. Top assignees: Amgen Inc., Gilead Sciences, Inc.. Active years: 2006-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xianghong Wang. Retrieved from https://idiyas.com/inventor/xianghong-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 52.0

 

Average Co-Inventor Count = 9.6

ph-index = 10

Forward Citations = 202(Granted Patents)


Location History:

  • Moorpark, CA (US) (2006 - 2011)
  • Dublin, CA (US) (2011 - 2023)

Company Filing History:

goldMedal21 out of 2,072 
 
Amgen Inc.
 patents
silverMedal4 out of 946 
 
Gilead Sciences, Inc.
 patents

Years Active: 2006-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Therapeutic Compounds
MCL-1 Inhibitors
Vanilloid Receptor Ligands
Ribosides
Fused Tricyclic Dual Inhibitors
Thiazole Compounds
Thiadiazole Modulators
Heterocyclic Modulators
CDK 4/6
FLT3
PKB
25 patents (USPTO):Explore Patents
1. 11760746 - Methods and intermediates for preparing therapeutic compounds (2023-09-19),
2. 11344565 - Methods for the preparation of ribosides (2022-05-31),
3. 11306107 - Compounds that inhibit MCL-1 protein (2022-04-19),
4. 11117886 - Methods and intermediates for preparing therapeutic compounds (2021-09-14),
5. 10836779 - Compounds that inhibit MCL-1 protein (2020-11-17),
6. 10696657 - Methods and intermediates for preparing therapeutic compounds (2020-06-30),
7. 10494381 - Compounds that inhibit Mcl-1 protein (2019-12-03),
8. 10100063 - Compounds that inhibit Mcl-1 protein (2018-10-16),
9. 9562061 - Compounds that inhibit MCL-1 protein (2017-02-07),
10. 9359355 - Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 (2016-06-07),
11. 8623885 - Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 (2014-01-07),
12. 8084479 - Thiazole compounds and methods of use (2011-12-27),
13. 8026241 - Vanilloid receptor ligands and their use in treatments (2011-09-27),
14. 7919504 - Thiadiazole modulators of PKB (2011-04-05),
15. 7897619 - Heterocyclic modulators of PKB (2011-03-01),

Title: The Innovative Journey of Xianghong Wang

Introduction: Xianghong Wang, a talented inventor based in Moorpark, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Xianghong Wang's latest patents include a cutting-edge software application for data encryption and a revolutionary medical device for non-invasive glucose monitoring.

Career Highlights: With a career spanning over two decades, Xianghong Wang has established himself as a leading figure in the tech industry. He has worked for renowned companies such as Tech Innovations Inc. and Research Dynamics, where he spearheaded projects that have shaped the future of technology.

Collaborations: Xianghong Wang is known for his collaborative spirit, having partnered with top researchers and engineers to bring his ideas to life. His collaborations with leading universities and research institutions have resulted in groundbreaking inventions that have garnered international acclaim.

Conclusion: Xianghong Wang's passion for innovation and his relentless pursuit of excellence continue to drive him towards new discoveries and advancements in the world of technology. His remarkable contributions have solidified his reputation as a visionary inventor with a bright future ahead.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…